Lupin launches Darunavir Tablets in the United States

Global pharma major Lupin Limited (Lupin) today announced the launch of Darunavir Tablets, 600 mg and 800 mg, to market a generic equivalent of Prezista® Tablets of Janssen Products, LP.

Darunavir Tablets, 600 mg and 800 mg (RLD Prezista®) had estimated annual sales of USD 308 million in the U.S. (IQVIA MAT March 2023).

Shares of Lupin Limited was last trading in BSE at Rs. 817.15 as compared to the previous close of Rs. 811.50. The total number of shares traded during the day was 21526 in over 1098 trades.

The stock hit an intraday high of Rs. 820.40 and intraday low of 806.50. The net turnover during the day was Rs. 17508741.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 ProductLaunch DarunavirTablets PrezistaTablets JanssenProducts